How many studies have been conducted on Fibroblast Growth Factor 23?

BiohacksAI has indexed 299 PubMed studies on Fibroblast Growth Factor 23, including 3 randomized controlled trials (RCTs). 46% of studies involve human subjects.

What are the main research areas for Fibroblast Growth Factor 23?

The primary research domains for Fibroblast Growth Factor 23 are 🫘 Kidney, 🦴 Bone & Joint, 🧬 Hormones. This is based on analysis of 299 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Fibroblast Growth Factor 23

A specific fibrobroblast growth factor that is primarily synthesized by OSTEOCYTES and OSTEOBLASTS. It is involved in regulating phosphate homeostasis and renal phosphate excretion.

299+ PubMed studies analyzed · 3 RCTs · Evidence Score: 49.6

Research Domains

Fibroblast Growth Factor 23 has been studied across 14 research domains including 🫘 Kidney, 🦴 Bone & Joint, 🧬 Hormones, ❤️ Cardiovascular, 🔬 Oncology. The primary research focus is 🫘 Kidney with 51% of studies addressing this area.

Loading evidence profile...

This evidence profile for Fibroblast Growth Factor 23 is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.